The ROC curve applied to assess the sensitivity and specificity of ACSL1 for the outcome prediction of ccRCC in TCGA data sets, exhibiting an area beneath the ROC curve of 0.814 (95% CI: 0.769–0.859) (Fig. 2D). Here, ACSL1 is linked to nonpapillary renal cell carcinoma.